Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03905928 · ClinicalTrials.gov registry record · NA
Establishing the Effect of Flavor on the Addictive Potential of Electronic Cigarettes
A NA study, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT03905928 is a NA study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 19 participants.
The verdict
NCT03905928, a NA study, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
The current study aims to establish proof-of-concept that neural cue-reactivity can serve as an early, objective marker of electronic cigarette (ECIG) addictive potential. Further, this study will examine the effect of flavor and nicotine concentration on the addictive potential of ECIGs to aid research informing U.S. Food and Drug Administration (FDA) flavor regulations and smoking cessation.
Interventions
- OTHER Nicotine Containing ECIG with tobacco flavor
- OTHER Nicotine Containing ECIG with Strawberry Vanilla Flavor
- OTHER Placebo ECIG with Tobacco Flavor
- OTHER Placebo ECIG with Strawberry Vanilla Flavor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2019-11-04 |
| Est. Completion | 2024-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03905928
The ClinicalTrials.gov registry entry for NCT03905928 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Nicotine Containing ECIG with tobacco flavor is the first listed.
NCT03905928 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03905928 about?
NCT03905928 is a clinical study titled "Establishing the Effect of Flavor on the Addictive Potential of Electronic Cigarettes". The current study aims to establish proof-of-concept that neural cue-reactivity can serve as an early, objective marker of electronic cigarette (ECIG) addictive potential. Further, this study will examine the effect of flavor and nicotine concentration on the addictive potential of ECIGs to aid rese...
What is the current status of trial NCT03905928?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2019-11-04. Estimated completion is 2024-04-30.
What interventions are being tested in trial NCT03905928?
The interventions under investigation include: Nicotine Containing ECIG with tobacco flavor (OTHER), Nicotine Containing ECIG with Strawberry Vanilla Flavor (OTHER), Placebo ECIG with Tobacco Flavor (OTHER), Placebo ECIG with Strawberry Vanilla Flavor (OTHER).
Who is sponsoring clinical trial NCT03905928?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.